Cas:801-52-5 Porfiromycin manufacturer & supplier

We serve Chemical Name:Porfiromycin CAS:801-52-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Porfiromycin

Chemical Name:Porfiromycin
CAS.NO:801-52-5
Synonyms:N-methylmitomycin C;porphiromycin;Methyl MitoMycin C;Methylmitomycin;RegaMycin;Porfiromycine;porfiromycin;8-Azathioxanthine
Molecular Formula:C16H20N4O5
Molecular Weight:348.35400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:560.9ºC at 760 mmHg
Density:1.52g/cm3
Index of Refraction:1.672
PSA:127.96000
Exact Mass:348.14300
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-methylmitomycin C chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-Azathioxanthine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Azathioxanthine Use and application,Methyl MitoMycin C technical grade,usp/ep/jp grade.


Related News: In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. 1-(4-chloro-2-fluoro-5-isopropoxyphenyl)piperidine-2-carboxamide manufacturers For Franco Stevanato, tapping public markets will give the company the freedom to keep innovating as it enters the next chapter of its 70-plus-year history. methyl (3R)-3,7-dimethyl-6-oxo-7-octenoate suppliers It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016. Benzamide, 4-[3-[(2-hydroxy-2-phenylethyl)amino]butyl]-N,N-dimethyl- vendor & factory The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction.,It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016.